Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 16151466

Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia: final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Leukemia
Publication date
2005 Nov
First author
Zwierzina H

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Zwierzina H
      type
      Author
    2. name
      Suciu S
      type
      Author
    3. name
      Loeffler-Ragg J
      type
      Author
    4. name
      Neuwirtova R
      type
      Author
    5. name
      Fenaux P
      type
      Author
    6. name
      Beksac M
      type
      Author
    7. name
      Harousseau J
      type
      Author
    8. name
      Nuessler V
      type
      Author
    9. name
      Cermak J
      type
      Author
    10. name
      Solbu G
      type
      Author
    11. name
      Willemze R
      type
      Author
    12. name
      de Witte T
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Zwierzina H
      type
      Author
    2. name
      Suciu S
      type
      Author
    3. name
      Loeffler-Ragg J
      type
      Author
    4. name
      Neuwirtova R
      type
      Author
    5. name
      Fenaux P
      type
      Author
    6. name
      Beksac M
      type
      Author
    7. name
      Harousseau J
      type
      Author
    8. name
      Nuessler V
      type
      Author
    9. name
      Cermak J
      type
      Author
    10. name
      Solbu G
      type
      Author
    11. name
      Willemze R
      type
      Author
    12. name
      de Witte T
      type
      Author
    bibliography ids
    1. nci-bib-870c4216cedc937a6e687ec0
    book metadata
    content sha256
    74d0bc26756a0066a8b1a8bc3606c35682b43bd3c3ec2879bb39cec8209357e5
    document type
    citation
    dois
    1. 10.1038/sj.leu.2403934
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:16151466
    immutable id
    pubmed:16151466@74d0bc26756a0066a8b1a8bc3606c35682b43bd3c3ec2879bb39cec8209357e5
    journal
    abbreviation
    Leukemia
    issn electronic
    Source null
    issn print
    0887-6924
    issue
    11
    name
    Leukemia
    nlm unique id
    8704895
    pages
    1929-33
    volume
    19
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      16151466
      provenance
      batch id
      acd1a19ec1fd03e5b423
      provider
      NCBI PubMed ESummary
      record sha256
      09db3e39ff14619a185cbc49b158c3a8b8a638c2162f193cf06d366c33a0f084
      response sha256
      06f2789b1faf1384eea463ec33b6ace6458084d0e39588df6f3b23cecac27647
      retrieved at
      2026-09-09T23:46:01.895425+00:00
      publication date
      display
      2005 Nov
      precision
      month
      year
      2005
      publication types
      1. Clinical Trial
      2. Clinical Trial, Phase III
      3. Journal Article
      4. Multicenter Study
      5. Randomized Controlled Trial
      6. Research Support, N.I.H., Extramural
      7. Research Support, Non-U.S. Gov't
      8. Research Support, U.S. Gov't, P.H.S.
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/16151466/
      title
      Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia: final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative Group.

      Preserved source evidence · Not medical advice